BEC Chemicals Pvt. Ltd.

becchemicals.com

BEC Chemicals Pvt. Ltd specializes in manufacturing of Active pharmaceutical Ingredients (API’s) and Intermediates. The manufacturing unit in Roha (Raigad dist.) has been approved by Indian and European Drug Authority and is EU-GMP, WHO-GMP and State GMP certified. The company is ISO 9001:2008, 14001:2004, 18000:2007, OHSAS certified by SGS-UK. The manufacturing unit is a 100% Export Oriented Unit and is recognized as STAR EXPORT house by DGFT (INDIA). Recently we have been approved by USFDA.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

BLUESTAR GENOMICS RECEIVES CAP ACCREDITATION FOR ITS CLINICAL LABORATORY

Bluestar Genomics | October 11, 2022

news image

Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy tests focused on non-invasive detection of high-mortality cancers in high-risk patient populations, today announced it received accreditation for its clinical laboratory from the College of American Pathologists (CAP). The certification enables the company to serve physicians and patients globally as it works towards broad commercialization of its first test f...

Read More

Pharmacy Market

TRANSACTION DATA SYSTEMS ACHIEVES KLOUDSCRIPT, A CLOUD-BASED SPECIALTY PHARMACY SOLUTION

Transaction Data Systems | November 25, 2020

news image

Exchange Data Systems (TDS), the pioneer in drug store programming answers for the network drug store market, today reported the obtaining of KloudScript, a strength drug store care arrangement. Right now 39% of network drug stores apportion a type of strength prescriptions, agreeing the National Community Pharmacy Association. Interest for strength meds has been consistently ascending to treat explicit sickness states and the constantly sick. With the maturing populace and the ex...

Read More

Business Insights

RESILIENCE ESTABLISHES MULTI-PRODUCT DEVELOPMENT AND MANUFACTURING COLLABORATION WITH TAKEDA’S PLASMA-DERIVED THERAPIES BUSINESS UNIT

Resilience | February 16, 2022

news image

National Resilience, Inc. a technology-focused manufacturing company dedicated to broadening access to complex medicines, announced a manufacturing services agreement with Takeda’s Plasma-Derived Therapies Business Unit. As part of the agreement, Resilience will focus on supporting the development and manufacture of multiple products in Takeda’s plasma-derived medicines portfolio out of its facility in Mississauga, Ontario. “I...

Read More

IONIS AND GENUITY SCIENCE ANNOUNCE AGREEMENT DESIGNED TO RAPIDLY TRANSLATE GENOMIC INSIGHTS INTO THERAPEUTICS

Prnewswire | October 01, 2020

news image

Genuity Science, a genomics and data insights organization and Ionis Pharmaceuticals (NASDAQ: IONS), the leader in antisense therapeutics, today announced a broad, multi-year collaboration aimed at accelerating the discovery and development of innovative therapeutics across a range of up to 20 diseases. The collaboration is expected to play an important role in allowing Ionis to continue delivering transformational medicines to patients for many years to come. Genuity Science's approach comb...

Read More
news image

Pharma Tech

BLUESTAR GENOMICS RECEIVES CAP ACCREDITATION FOR ITS CLINICAL LABORATORY

Bluestar Genomics | October 11, 2022

Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy tests focused on non-invasive detection of high-mortality cancers in high-risk patient populations, today announced it received accreditation for its clinical laboratory from the College of American Pathologists (CAP). The certification enables the company to serve physicians and patients globally as it works towards broad commercialization of its first test f...

Read More
news image

Pharmacy Market

TRANSACTION DATA SYSTEMS ACHIEVES KLOUDSCRIPT, A CLOUD-BASED SPECIALTY PHARMACY SOLUTION

Transaction Data Systems | November 25, 2020

Exchange Data Systems (TDS), the pioneer in drug store programming answers for the network drug store market, today reported the obtaining of KloudScript, a strength drug store care arrangement. Right now 39% of network drug stores apportion a type of strength prescriptions, agreeing the National Community Pharmacy Association. Interest for strength meds has been consistently ascending to treat explicit sickness states and the constantly sick. With the maturing populace and the ex...

Read More
news image

Business Insights

RESILIENCE ESTABLISHES MULTI-PRODUCT DEVELOPMENT AND MANUFACTURING COLLABORATION WITH TAKEDA’S PLASMA-DERIVED THERAPIES BUSINESS UNIT

Resilience | February 16, 2022

National Resilience, Inc. a technology-focused manufacturing company dedicated to broadening access to complex medicines, announced a manufacturing services agreement with Takeda’s Plasma-Derived Therapies Business Unit. As part of the agreement, Resilience will focus on supporting the development and manufacture of multiple products in Takeda’s plasma-derived medicines portfolio out of its facility in Mississauga, Ontario. “I...

Read More
news image

IONIS AND GENUITY SCIENCE ANNOUNCE AGREEMENT DESIGNED TO RAPIDLY TRANSLATE GENOMIC INSIGHTS INTO THERAPEUTICS

Prnewswire | October 01, 2020

Genuity Science, a genomics and data insights organization and Ionis Pharmaceuticals (NASDAQ: IONS), the leader in antisense therapeutics, today announced a broad, multi-year collaboration aimed at accelerating the discovery and development of innovative therapeutics across a range of up to 20 diseases. The collaboration is expected to play an important role in allowing Ionis to continue delivering transformational medicines to patients for many years to come. Genuity Science's approach comb...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us